Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Syndax Pharmaceuticals, Inc.(SNDX) | 8,050,959 | 8,050,959 | 0 | $169.15M | $188.07M | 11.94% | +$18.92M |
| Celldex Therapeutics, Inc.(CLDX) | 5,943,180 | 5,840,567 | -102,613 | $161.42M | $185.26M | 11.76% | +$23.85M |
| Vaxcyte, Inc.(PCVX) | 2,922,335 | 2,922,335 | 0 | $134.84M | $169.82M | 10.78% | +$34.98M |
| Cogent Biosciences, Inc.(COGT) | 6,165,223 | 4,037,331 | -2,127,892 | $218.99M | $155.40M | 9.86% | -$63.59M |
| Vera Therapeutics, Inc.CL A(VERA) | 3,433,051 | 3,398,224 | -34,827 | $173.85M | $136.71M | 8.68% | -$37.14M |
| Beam Therapeutics Inc.(BEAM) | 2,440,214 | 3,682,185 | +1,241,971 | $67.64M | $87.75M | 5.57% | +$20.10M |
| CytomX Therapeutics, Inc.(CTMX) | 8,966,077 | 15,013,093 | +6,047,016 | $38.20M | $70.56M | 4.48% | +$32.37M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 9,366,526 | 5,680,795 | -3,685,731 | $73.06M | $54.08M | 3.43% | -$18.98M |
| Travere Therapeutics, Inc.(TVTX) | 517,884 | 1,569,018 | +1,051,134 | $19.79M | $46.62M | 2.96% | +$26.83M |
| Viridian Therapeutics, Inc.(VRDN) | 1,470,541 | 2,341,652 | +871,111 | $45.76M | $45.80M | 2.91% | +$39.5K |
| Cullinan Therapeutics, Inc.(CGEM) | 3,114,132 | 3,114,132 | 0 | $32.23M | $44.25M | 2.81% | +$12.02M |
| UroGen Pharma Ltd.(URGN) | 0 | 2,247,393 | +2,247,393 | $0 | $40.41M | 2.56% | +$40.41M |
| Kalvista Pharmaceuticals Inc | 1,810,954 | 1,820,954 | +10,000 | $29.25M | $36.66M | 2.33% | +$7.41M |
| Apellis Pharmaceuticals Inc COM | 908,607 | 825,000 | -83,607 | $22.82M | $33.19M | 2.11% | +$10.37M |
| Legend Biotech CorporationADS(LEGN) | 0 | 1,576,295 | +1,576,295 | $0 | $28.52M | 1.81% | +$28.52M |
| MBX Biosciences, Inc.(MBX) | 934,799 | 934,799 | 0 | $29.48M | $27.90M | 1.77% | -$1.58M |
| Immunocore Holdings plcADS(IMCR) | 856,462 | 884,937 | +28,475 | $29.73M | $26.68M | 1.69% | -$3.05M |
| Sutro Biopharma, Inc.(STRO) | 479,590 | 872,558 | +392,968 | $5.55M | $21.74M | 1.38% | +$16.19M |
| Burning Rock Biotech LimitedADS(BNR) | 994,883 | 1,227,555 | +232,672 | $20.05M | $19.79M | 1.26% | -$256.4K |
| Soleno Therapeutics Inc | 0 | 560,000 | +560,000 | $0 | $18.75M | 1.19% | +$18.75M |
| Nurix Therapeutics, Inc.(NRIX) | 1,970,357 | 1,194,757 | -775,600 | $37.38M | $18.52M | 1.18% | -$18.86M |
| Pharvaris N V COM | 640,395 | 640,395 | 0 | $17.77M | $18.09M | 1.15% | +$320.2K |
| Evommune, Inc.(EVMN) | 185,482 | 625,496 | +440,014 | $3.18M | $14.38M | 0.91% | +$11.20M |
| Relay Therapeutics, Inc.(RLAY) | 1,424,259 | 1,424,259 | 0 | $12.05M | $14.17M | 0.90% | +$2.12M |
| Geron Corporation(GERN) | 3,456,318 | 6,836,318 | +3,380,000 | $4.56M | $10.19M | 0.65% | +$5.62M |
| Engene Holdings Inc COM | 1,492,898 | 1,356,843 | -136,055 | $13.48M | $9.24M | 0.59% | -$4.24M |
| Design Therapeutics, Inc.(DSGN) | 784,606 | 784,606 | 0 | $7.36M | $8.35M | 0.53% | +$988.6K |
| Wave Life Sciences, Inc.SHS(WVE) | 2,169,105 | 965,193 | -1,203,912 | $36.87M | $7.00M | 0.44% | -$29.88M |
| Climb Bio, Inc.(CLYM) | 1,028,341 | 1,003,341 | -25,000 | $4.11M | $6.87M | 0.44% | +$2.76M |
| Amarin Corp PlcADR | 389,273 | 472,382 | +83,109 | $5.43M | $6.83M | 0.43% | +$1.40M |
| Biohaven Ltd.(BHVN) | 702,884 | 702,884 | 0 | $7.94M | $5.95M | 0.38% | -$1.99M |
| Prelude Therapeutics Incorporated(PRLD) | 788,867 | 1,592,551 | +803,684 | $2.29M | $5.45M | 0.35% | +$3.16M |
| Caribou Biosciences, Inc.(CRBU) | 2,503,302 | 2,503,302 | 0 | $3.98M | $4.76M | 0.30% | +$776.0K |
| Alector Inc | 2,000,000 | 2,000,000 | 0 | $3.12M | $4.30M | 0.27% | +$1.18M |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 1,566,317 | 1,566,317 | 0 | $3.16M | $2.54M | 0.16% | -$626.5K |
| Candel Therapeutics, Inc.(CADL) | 0 | 200,000 | +200,000 | $0 | $980.0K | 0.06% | +$980.0K |
| CG Oncology, Inc.(CGON) | 945,830 | 0 | -945,830 | $39.27M | $0 | — | -$39.27M |
| Dynavax Technologies Corp | 1,375,632 | 0 | -1,375,632 | $21.16M | $0 | — | -$21.16M |
| Tyra Biosciences, Inc.(TYRA) | 1,564,492 | 0 | -1,564,492 | $41.13M | $0 | — | -$41.13M |